(S)-1-(4-fluoro-1-methyl-1H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo(4,3-c)pyridin-3-yl)-1,3-dihydro-2H-imidazol-2-one

It forms the core scaffold of the oral, non-peptide GLP-1 receptor agonist designed for Type 2 diabetes and obesity. (S)-1-(4-fluoro-1-methyl-1H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[3-c]pyridin-3-yl)-1,3-dihydro-2H-imidazol-2-one is a critical advanced intermediate employed to synthesize Orforglipron.

API Name Orforglipron
CAS No 2212022-56-3
Molecular Formula C26H25F2N7O
Molecular Weight 489.5 g/mol
Synonyms 1-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-yl]-3-(4-fluoro-1-methylindazol-5-yl)imidazol-2-one

Frequently Asked Questions